April 2017 |
|
acrobat040717 Wyden Letter to HHS Counsel Davis on HMA recusal |
|
acrobat040517 Wyden Letter to IRS Commissioner Rettig on Resources |
March 2017 |
|
acrobatWyden Shaub Letter on Mnuchin RPD Comments |
|
acrobat031717 Wyden Letter to HHS Acting Gen Counsel Davis on Verma Ethics |
|
acrobat030417 Wyden Pallone Letter to HHS Sec Price on Medicaid Flexibility |
|
acrobat011017 CMS Acting Admin Slavitt Letter to Wyden on Payroll Tax Medicare Solvency |
|
acrobat030717 Wyden Stabenow Letter to Hatch Requesting Trump Tax Returns |
October 2016 |
|
acrobat100516 CMS Acting Admin Slavitt Response Letter to Wyden on EpiPen Pricing |
September 2016 |
|
acrobat090216 Wyden Pallone Letter to HHS Sec Burwell on EpiPens and Medicaid |
June 2016 |
|
acrobat062316 Wyden Letter to Burwell regarding IPRCC |
|
acrobat061516 Wyden Letter to Acting DEA Admin Rosenberg on Fentanyl |
May 2016 |
|
acrobat052016 Wyden letter to CBP Commissioner Kerlikowske on Fentanyl |
|
acrobat051016 Wyden letter to Wyoming Sec of State Murray on Shell Companies |
|
acrobat051016 Wyden letter to Nevada Sec of State Cegavske on Shell Companies |
March 2016 |
|
acrobatBenjamin Gerritz |